Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace 9th Digital Pharma Europe
Site Search:
    Home Open Innovation Engaged Thinking Patient Engagement Events News Careers Directory
 Innovation Blogs and News   Close Portlet and Return to previous page

Singapore QuickFire Challenge - Metabolic Disease Innovation
The QuickFire Challenge will award the entrepreneur, academic, and biotech researchers who submit the best ideas, technologies, or solutions holding the potential of making a major difference to the millions of people in Asia Pacific and around the world who suffer from metabolic diseases such as diabetes and obesity. Winners will be awarded with SGD100,000 project money, access to ETPL laboratory space and one year of mentorship and coaching by Johnson & Johnson Innovation, ETPL and SMART staff.

The initiative underscores Johnson & Johnson’s strong commitment to working in partnership to nurture the healthcare ecosystem in global innovation hotspots around the world, like Singapore, with the aim of positively impacting human health through innovation. The Challenge demonstrates Johnson & Johnson Innovation’s unique vision for collaboration in an open innovation model, aiming to combine Johnson & Johnson Innovation’s global reach and expertise with Singapore’s unique capabilities in innovation to identify breakthrough solutions for the diagnosis and/or treatment of metabolic diseases.
Read More...

Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.
Read More...

The Evolution of Patient Engagement at FDA
Although advancements in incorporating the patient voice have been made over the past few decades, there are still patients who feel frustrated with the rate of progress.
Read More...

Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
This is the question eyeforpharma answers in its latest whitepaper on GSK's radical new customer engagement model. Read the full paper here
https://goo.gl/w0H9k7

Lessons for Patient Driven Innovation: Rebuild Personas According to Your Next Product Innovation
By exclusively focusing on your persona’s one main need and trying hard to fulfill that need with your product, you can build the next feature with a more focused vision.
Read More...

Culture and Process Change for Patient Engagement
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions.
Read More...

Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.
Read More...

Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.
Read More...

It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.
Read More...

Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Read More...

Innovation Communities
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.
Read More...

WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Read More...

Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.
Read More...

Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients.
Read More...
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles.
Read More...

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.

Partnership between Pharma and Patients

Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients.
Read More...

Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology.
Read More...

A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

Engaging patients for drug repurposing: Mapping the patient engagement continuum
November 2015
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.

Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.
Read More...

Patient Engagement/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Read More...

Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Read More...

Continuing Reading More Innovation News and Blogs...


Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2017 CanBiotech™ Inc.